DaVita Target Price

See DaVita's analyst price targets ($240) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$174.67

Average Target Price

$235.25

34.7% upside

8 analysts in the last 4 months

High: $270 | Low: $215

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-07	Truist Financial	$215	23.1% upside
2026-08-07	Oppenheimer	$220	26% upside
2026-08-07	Raymond James	$220	26% upside
2026-08-05	Deutsche BankPito Chickering	$265	51.7% upside
2026-08-05	BarclaysAndrew Mok	$224	28.2% upside
2026-07-14	Truist Financial	$250	43.1% upside
2026-07-10	UBS	$270	54.6% upside
2026-07-08	Barclays	$218	24.8% upside
2026-05-08	Truist Financial	$205	17.4% upside
2026-05-07	BarclaysAndrew Mok	$194	11.1% upside
2026-05-06	Deutsche BankPito Chickering	$220	26% upside
2026-02-05	Truist Financial	$158	9.5% downside
2026-02-04	UBS	$190	8.8% upside
2026-02-03	Barclays	$158	9.5% downside
2025-10-30	Barclays	$143	18.1% downside
2025-10-14	Truist FinancialDavid MacDonald	$140	19.8% downside
2025-10-09	BarclaysAndrew Mok	$149	14.7% downside
2025-08-08	Truist FinancialDavid MacDonald	$148	15.3% downside
2025-02-21	BernsteinLisa Bedell Clive	$184	5.3% upside
2024-08-07	Bank of America SecuritiesKevin Fischbeck	$145	17% downside
2024-05-06	BarclaysAndrew Mok	$150	14.1% downside
2022-10-31	BarclaysSarah James	$81	53.6% downside
2022-08-19	UBSAndrew Mok	$117	33% downside
2022-06-28	Truist FinancialDavid MacDonald	$90	48.5% downside

DaVita (DVA) FAQ

DaVita posts a target price of $240. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $240 for DVA means covering analysts, on average, see the stock 34.7% upside of $174.67 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for DVA's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; DaVita's other metric pages and overview cover the third.

Judging DaVita against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $240 here, then scan peer and history charts to see if the gap is persistent.